sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its position regarding its interests in Mural Oncology plc, in line with Rule 8.3 of the Irish Takeover Panel Act, 1997. As of May 29, 2025, Vanguard holds 772,885 $0.01 ordinary shares, equating to a 4.48% interest in Mural Oncology. This disclosure does not include any interests in additional parties related to the offer.
Vanguard reported a minor transaction involving the sale of 18 shares at a price of $2.64 per unit. There are no cash-settled or stock-settled derivative positions to disclose, and no supplemental Form 8 is attached to this disclosure.
No indemnity or option arrangements exist that might influence dealings. Similarly, no agreements affect voting rights or future securities transactions. The document also confirms that there are no other relevant dealings or new securities transactions.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.